➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Last Updated: October 16, 2021

DrugPatentWatch Database Preview

Litigation Details for MV3 Partners LLC v. Roku, Inc. (W.D. Tex. 2018)

Email this page to a colleague

« Back to Dashboard

MV3 Partners LLC v. Roku, Inc. (W.D. Tex. 2018)

Docket ⤷  Free Forever Trial Date Filed 2018-10-16
Court District Court, W.D. Texas Date Terminated
Cause 35:271 Patent Infringement Assigned To Alan D. Albright
Jury Demand Plaintiff Referred To
Patents 10,526,657; 6,913,903; 7,012,066; 9,254,308; 9,340,830
Attorneys Alexander J. Hadjis; Andy W. Tindel; Craig D. Cherry; Darcy L. Jones; Darryl Adams; David N. Deaconson; G. Blake Thompson; Gurtej Singh; Heather S. Kim; J. Mark Mann; Jack Shaw; John W. Downing; Jonathan K. Waldrop; Lisa M. Mandrusiak; Marcus A. Barber; Michael D. West; Paul G. Williams; Richard D. Milvenan; ThucMinh Nguyen; Tia D. Fenton; W. Todd Baker
Firms Haley & Olson, P.C.; Hogan Lovells US LLP; Kasowitz Benson Torres LLP; Kasowitz Benson Torres, LLP; Kawowitz Benson Torres, LLP; Mann Tindel Thompson; Mann, Tindel & Thompson, Attorneys at Law; Mann, Tindel, Thompson; McGinnis, Lochridge & Kilgore, L.L.P.; Oblon, McClelland, Maier & Neustadt, L.L.P.; Oblon, McClelland, Maier & Neustadt, LLP; Oblon, McClelland, Maier & Newstadt, LLP; Pakis, Giotes, Page & Burleson; Slayden Grubert Beard PLLC
Link to Docket External link to docket
Small Molecule Drugs cited in MV3 Partners LLC v. Roku, Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .
Biologic Drugs cited in MV3 Partners LLC v. Roku, Inc.

Details for MV3 Partners LLC v. Roku, Inc. (W.D. Tex. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-04-22 201 In Limine Telephone: (903) 657-8540 Facsimile: (903) 657-6003 …assert patent rights without practicing the patent, or suggestions that MV3 was assigned patent rights… 8 relating to patent infringement or the Patent Office – much less the patent-in-suit. Thus, any …involving EVM”); Mars, Inc. v. TruRX LLC, No. 6:13-CV-526-RWS-KNM, 2016 WL 4055675, at *2-3 (E.D. Tex. Apr…and/or pejorative references to MV3 as a patent troll, patent assertion entity, and/or a non-practicing External link to document
2020-05-19 274 Transcript Filed 16 October 2018 6:18-cv-00308 830 Patent Plaintiff District Court, W.D…Reporter/Transcriber: Kristie Davis, Telephone number: 254-340-6114. Parties are notified of their duty to review…not electronically noticed Redaction Request due 6/9/2020, Redacted Transcript Deadline set for 6/19/2020 External link to document
2019-08-13 87 Exhibit 2 - Roku's Preliminary Invalidity Contentions 00308-ADA Document 87-3 Filed 08/13/19 Page 7 of 12 66 Nokia N80 User Guide …55, 56, 57, 59, and 61 (Asserted Claims) of U.S. Patent No. 8,863,223. Roku is providing: (1) charts…limited to the technology described in the prior art patents, publications, and manuals identified herein. …charts, each of the asserted claims of the ’223 patent is invalid under 35 U.S.C. §§ 102, 103. Each of…art before the alleged priority date of the ’223 patent. Roku contends that each prior art reference identified External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.